Vitafoods Europe 2027: let’s meet up in Barcelona
Starting a project
FAQ

Manufacturing and Formulation

Capsules, tablets or sachets: the form you choose determines both the stability of your active ingredients and your consumers’ experience. Discover our dry dosage forms, our equipment and the manufacturing conditions at our Saint-Bonnet-de-Rochefort site.

How is CranFlorya taken?

CranFlorya is taken as a short seven-day course: one probiotic capsule (Lactobacillus acidophilus) and one cranberry capsule per day. The formula is packaged in one blister of 14 capsules (7+7), transparent, size 0.

Where are the PiLeJe group’s products manufactured?

Dry forms are manufactured in France, at the Saint-Bonnet-de-Rochefort industrial site, in the Allier, a high-technology site certified to FSSC 22000.

What products does PiLeJe CDMO manufacture?

PiLeJe CDMO manufactures food supplements in dry forms — capsules, tablets, sachets and powders — in France.

Does PiLeJe CDMO develop and manufacture in France?

Yes, PiLeJe CDMO designs, develops and manufactures its food supplements in France, at its Saint-Bonnet-de-Rochefort site, in the Allier. From formula to production, all the know-how is French.

Can the plant formulate and package probiotics and sensitive actives?

Yes. The site formulates and packages probiotics in controlled-atmosphere production environments, with areas maintained at 18 °C and 30% relative humidity, designed to preserve strain viability. This command draws on 30 years of microbiota expertise and on in-process microbiological controls.

What is the production capacity of the Saint-Bonnet-de-Rochefort plant?

The site produces up to 825 million capsules and tablets per year, that is 25 million finished products (around 100,000 per day). A €25 million industrial plan launched in 2018 increased this capacity by 25%, to support our clients’ growth across 350 distinct formulations.

Where are PiLeJe CDMO’s food supplements manufactured?

PiLeJe CDMO’s food supplements are manufactured in France, at the Saint-Bonnet-de-Rochefort site, in the Allier. This high-technology site commands the entire chain, from the selection of raw materials to batch release. It is certified to the FSSC 22000 standard and operates in accordance with the requirements of the FDA 21 CFR Part 111 framework.

What levels of automation secure production?

Production is automated from the receipt of raw materials to cartoning: automated allocation of raw materials, a weighing centre guided down to the batch number, closed-circuit feeding of equipment, and three fully automated blister lines. This automation reduces the risk of error and secures every batch.

What equipment does the PiLeJe CDMO production site have?

The site brings together the main equipment families for dry forms: single-layer and bilayer tablet presses, capsule-filling machines, mixing equipment, a connected weighing workshop, and packaging lines for sachets, blisters and bottles. Powder transfer takes place in a closed circuit, and the whole is driven by the Sage ERP.

Can several different products be packaged in the same blister?

Yes. Two distinct formulations sharing the same dosage form can be brought together on a single blister through dual-product packaging — a daytime formula and a night-time formula, for example, or a plant and probiotic combination. This format supports adherence by grouping complementary doses.

Can the colour of the bottles be customised?

Yes, bottles and their caps can be coloured on request, alongside the standard white formats. Bottles are available in PET, RPET or plant-based HDPE, with clip-on, tamper-evident or desiccant caps.

Do you produce sample sachets?

Yes, PiLeJe CDMO produces sample sachets containing capsules or tablets. This format serves your promotional campaigns and your new product launches.

How do you guarantee the stability of probiotics in sachets?

The stability of probiotics in sachets rests above all on moisture control. Our four-side sealed sachets form a barrier against moisture and oxygen, while our formulations rely on over-dried excipients that maintain a minimal water activity (Aw), essential to the survival of the strains. Viability is then verified on every batch of finished product before release.

What are the main families of dosage form?

PiLeJe CDMO has command of dry forms: capsules, tablets and powders in sachets. Each form answers specific needs: dosing precision, high concentration or ease of use.

Why is the dosage form decisive for a food supplement?

The dosage form is decisive for how the product performs: stability of the actives, bioavailability, the way it is released in the body. It also plays a key role in adherence, by making the product easier for the consumer to take.

What is the dosage form of a food supplement?

The dosage form is the set of techniques that turn actives into a form ready to be taken: capsule, tablet or powder. Beyond the format itself, the dosage form chosen shapes the product’s efficacy, how it is absorbed by the body and the consumer experience.

Can you produce tablets with specific release profiles?

Yes. PiLeJe CDMO develops sustained-release and delayed-release tablets, as well as bilayer formats, according to the effect sought. These options come in addition to uncoated, film-coated and chewable tablets.

What secures the stability of probiotics in your formulations?

The viability of probiotic strains rests on a suitable dosage form and packaging, and on control of the manufacturing conditions: temperature at 18 °C, relative humidity at 30%, over-dried excipients. Viability is verified on every batch before release.

What dosage forms do you offer for food supplements?

PiLeJe CDMO offers plant-based capsules (sizes 1 to 00), tablets in various shapes (almond, scored, bilayer and others) and powders in sachets from 1 to 8 g. Other formats can be studied on request.

Which dosage forms are compatible with AminoNat®?

AminoNat® suits dry forms thanks to its good compressibility and good flow, capsules and tablets in particular. Sachets suit high concentrations of actives.

In which dosage forms can Ipowder® be incorporated?

Ipowder® fits into capsules, sachets and tablets, single-layer as well as bilayer. Its 100% plant nature makes clean-label formulation easier across all these forms.

How can the efficacy of sensitive active ingredients be preserved during a production scale-up?

Scaling up can generate thermal or mechanical stresses that may degrade vitamins, minerals, plant extracts and probiotic strains. Our teams optimise the particle size of blends, the homogeneity of powders during mixing and the speed of the industrial equipment to minimise these impacts. For probiotic formulation, the viability of the bacterial strains is safeguarded by a dedicated industrial environment: a constant temperature of 18 °C and relative humidity stabilised at 30%.

How do you secure the stability of probiotic strains at industrial scale?

The stability of probiotics rests on strict environmental control. Our dedicated production areas are held at 18 °C and 30% relative humidity, and our formulations rely on over-dried excipients that keep water activity to a minimum. Packaging then takes over, with barriers matched to the formula and airtight seals, and strain viability is verified on every batch before release.

image

Let’s develop your future nutraceutical range together

Looking to enrich your existing offer or launch a new brand with high-performance, high-quality products that are immediately available? Our experts will support you in making your selection.